Literature DB >> 28283911

Recovery of renal function after administration of adipose-tissue-derived stromal vascular fraction in rat model of acute kidney injury induced by ischemia/reperfusion injury.

Chunwoo Lee1, Myoung Jin Jang2, Bo Hyun Kim3, Jin Young Park3, Dalsan You3, In Gab Jeong3, Jun Hyuk Hong3, Choung-Soo Kim4.   

Abstract

Acute kidney injury (AKI) induced by ischemia/reperfusion (I/R) injury is a major challenge in critical care medicine. The purpose of this study is to determine the therapeutic effects of the adipose-tissue-derived stromal vascular fraction (SVF) and the optimal route for SVF delivery in a rat model of AKI induced by I/R injury. Fifty male Sprague-Dawley rats were randomly divided into five groups (10 animals per group): sham, nephrectomy control, I/R injury control, renal arterial SVF infusion and subcapsular SVF injection. To induce AKI by I/R injury, the left renal artery was clamped with a nontraumatic vascular clamp for 40 min, and the right kidney was removed. Rats receiving renal arterial infusion of SVF had a significantly reduced increase in serum creatinine compared with the I/R injury control group at 4 days after I/R injury. The glomerular filtration rate of the renal arterial SVF infusion group was maintained at a level similar to that of the sham and nephrectomy control groups at 14 days after I/R injury. Masson's trichrome staining showed significantly less fibrosis in the renal arterial SVF infusion group compared with that in the I/R injury control group in the outer stripe (P < 0.001). TUNEL labeling showed significantly decreased apoptosis in both the renal arterial SVF infusion and subcapsular SVF injection groups compared with the I/R injury control group in the outer stripe (P < 0.001). Thus, renal function is effectively rescued from AKI induced by I/R injury through the renal arterial administration of SVF in a rat model.

Entities:  

Keywords:  Acute kidney injury; Ischemia/reperfusion injury; Rat acute kidney injury model; Renal function; Stromal vascular fraction

Mesh:

Substances:

Year:  2017        PMID: 28283911     DOI: 10.1007/s00441-017-2585-0

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  6 in total

1.  Comparison of Stromal Vascular Fraction and Adipose-Derived Stem Cells for Protection of Renal Function in a Rodent Model of Ischemic Acute Kidney Injury.

Authors:  Joomin Aum; Myoung Jin Jang; Yu Seon Kim; Bo Hyun Kim; Dong Hyeon An; Jae Hyeon Han; Nayoung Suh; Choung-Soo Kim; Dalsan You
Journal:  Stem Cells Int       Date:  2022-05-06       Impact factor: 5.443

2.  Pioglitazone Protects Against Renal Ischemia-Reperfusion Injury via the AMP-Activated Protein Kinase-Regulated Autophagy Pathway.

Authors:  Wenlin Chen; Xiaoqing Xi; Shuangyang Zhang; Cong Zou; Renrui Kuang; Zhenfeng Ye; Yawei Huang; Honglin Hu
Journal:  Front Pharmacol       Date:  2018-08-06       Impact factor: 5.810

3.  Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury.

Authors:  Shani Zilberman-Itskovich; Ramzia Abu-Hamad; Rina Zarura; Marina Sova; Yafit Hachmo; Moshe Stark; Sara Neuman; Shimon Slavin; Shai Efrati
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

4.  Anti-apoptotic effect of adipose tissue-derived stromal vascular fraction in denervated rat muscle.

Authors:  R El-Habta; G Andersson; P J Kingham; L J Backman
Journal:  Stem Cell Res Ther       Date:  2021-03-04       Impact factor: 6.832

Review 5.  Adipose-Derived Stem/Stromal Cells in Kidney Transplantation: Status Quo and Future Perspectives.

Authors:  Gabriele Storti; Evaldo Favi; Francesca Albanesi; Bong-Sung Kim; Valerio Cervelli
Journal:  Int J Mol Sci       Date:  2021-10-17       Impact factor: 5.923

6.  Effect of apigenin on apoptosis induced by renal ischemia/reperfusion injury in vivo and in vitro.

Authors:  Xiao Wang; Wei Wang; Jian-Zhong Wang; Cheng Yang; Chao-Zhao Liang
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.